Minimum Net Sales. As of the last day of each Fiscal Quarter set forth below, Net Sales for the twelve (12) consecutive month period ending on the last day of such Fiscal Quarter shall not be less than the corresponding amount set forth opposite such Fiscal Quarter: June 30, 2022 $ 75,000,000 September 30, 2022 $ 75,000,000 December 31, 2022 $ 90,000,000 March 31, 2023 $ 90,000,000 June 30, 2023 $ 110,000,000 September 30, 2023 $ 110,000,000 December 31, 2023 $ 130,000,000 March 31, 2024 $ 130,000,000 June 30, 2024 $ 150,000,000 September 30, 2024 $ 150,000,000 December 31, 2024 $ 175,000,000 March 31, 2025 $ 175,000,000 June 30, 2025 $ 200,000,000 September 30, 2025 $ 200,000,000 December 31, 2025 $ 215,000,000 March 31, 2026 $ 215,000,000 June 30, 2026 $ 230,000,000 September 30, 2026 $ 230,000,000 December 31, 2026 and each Fiscal Quarter thereafter $ 250,000,000
Appears in 2 contracts
Sources: Credit Agreement and Guaranty (Adma Biologics, Inc.), Credit Agreement (Adma Biologics, Inc.)